Pharmacy- Page 46

Roche ranked the most sustainable healthcare company in the DJSI

November 16, 2020

Pharmacy

The FINANCIAL — For the eleventh time, Roche has been recognised as the most sustainable company in the Pharmaceuticals index of the Dow Jones Sustainability Indices (DJSI). This is based on an in-depth analysis of economic, social and environmental performance. The DJSI family of indices serves as a benchmark for investors who integrate sustainability considerations into their portfolios. Roche has

Gilead and Novo Nordisk announced new data from proof-of-concept trial in NASH

The FINANCIAL — Gilead Sciences, Inc. and Novo Nordisk A/S announced results

by The FINANCIAL

November 16, 2020

2 mins read

Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund

The FINANCIAL — Metagenomi, a next generation gene editing company launched by

by The FINANCIAL

November 12, 2020

1 min read

Pharmaceutical industries join to promise fair access to COVID-19 medicines and vaccines

The FINANCIAL — On the occasion of the World Health Assembly, the world’s

by The FINANCIAL

November 12, 2020

1 min read

Pharmacy

U.S. FDA Approves Once-daily Jentadueto XR Tablets

The FINANCIAL -- The U.S. Food and Drug Administration (FDA) has approved Jentadueto XR (linagliptin and metformin hydrochloride extended-release) tablets for the treatment of type 2 diabetes (T2D) in adults. JENTADUETO XR, which is marketed by Boehringer Ingelheim and Eli Lilly and

by The FINANCIAL

June 1, 2016

1 min read

Pharmacy

Allergan Receives FDA Approval of TEFLARO

The FINANCIAL -- Allergan plc on May 31 announced the U.S. Food and Drug Administration (FDA) has approved the company's supplemental New Drug Application (sNDA) for TEFLARO (ceftaroline fosamil), granting new indications for pediatric patients 2 months of age to less than

by The FINANCIAL

May 31, 2016

2 mins read

Pharmacy

Biogen Receives Positive CHMP Opinion for TYSABRI

The FINANCIAL -- The Committee of Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of a variation to the marketing authorization of TYSABRI (natalizumab), Biogen announced on May 31.

by The FINANCIAL

May 31, 2016

1 min read

Pharmacy

Teva Gets CRL From FDA For NDA For SD-809 Tablets For Chorea Associated With HD

The FINANCIAL -- Teva Pharmaceutical Industries Ltd. on May 31 announced that it has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) regarding the New Drug Application (NDA) for SD-809 (deutetrabenazine) tablets for the treatment of

by The FINANCIAL

May 31, 2016

1 min read

Pharmacy

Roche’s subcutaneous formulation of MabThera receives approval in Europe for people with chronic lymphocytic leukaemia

The FINANCIAL -- Roche announced on May 31 that the European Commission (EC) has approved the subcutaneous (SC) formulation of MabThera® (rituximab) for people with previously untreated and relapsed/refractory chronic lymphocytic leukaemia (CLL).

by The FINANCIAL

May 31, 2016

1 min read

Pharmacy

FLIXABI Approved in the European Union

The FINANCIAL -- The European Commission (EC) on May 30 granted marketing authorization in the European Union (EU) for FLIXABI, an infliximab biosimilar referencing Remicadei. FLIXABI was developed by Samsung Bioepis, the joint venture between Samsung BioLogics and Biogen.

by The FINANCIAL

May 30, 2016

1 min read

Pharmacy

Merck Receives Positive CHMP Opinion for ZEPATIER in the European Union

The FINANCIAL -- Merck, known as MSD outside the United States and Canada, on May 27 announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending approval of ZEPATIER

by The FINANCIAL

May 27, 2016

2 mins read

Pharmacy

Amgen Gets Positive CHMP Opinion To Extend Indication Of Kyprolis

The FINANCIAL -- Amgen on May 27 announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion to extend the current indication for Kyprolis (carfilzomib) to include treatment in combination with

by The FINANCIAL

May 27, 2016

1 min read

Pharmacy

Novel glaucoma therapy: One ‘ring’ to help them all?

The FINANCIAL -- Glaucoma patients struggling to adhere to a daily eye drop schedule may benefit from a nonsurgical inset that researchers say ensures effective delivery of intraocular pressure (IOP)-lowering drugs.

by The FINANCIAL

May 24, 2016

1 min read

Pharmacy

Pfizer Updates CHAMPIX To Add New Safety And Efficacy Data In European Union

The FINANCIAL -- Pfizer Inc. on May 23 announced that the European Summary of Product Characteristics (SmPC) and Package Leaflet for CHAMPIX (varenicline) have been updated to include safety and efficacy data from the EAGLES (Evaluating Adverse Events in a Global Smoking

by The FINANCIAL

May 23, 2016

1 min read